Zimmer Biomet has entered into a definitive agreement to purchase Paragon 28, a medical device company focused exclusively on foot-and-ankle orthopedics.

Zimmer Biomet shares at $105 reveal value at 13 times adjusted earnings, as the company continues to grow despite a GLP-1 ...

From acquisitions to quarterly updates, here are seven key developments from spine and orthopedic devicemakers since Jan. 22.

At the end of January, Zimmer Biomet acquired Paragon 28, a medical device company focused exclusively on foot-and-ankle orthopedics. Through the $1.1 billion acquisition, Zimmer Biomet expects its ...

Needham analyst Michael Matson has maintained their neutral stance on ZBH stock, giving a Hold rating on January 17.Invest with Confidence: ...

BD announced it would split from its biosciences and diagnostics unit, while Zimmer Biomet updated investors on its $1.1 ...

The firm also offers sports medicine, biologics, extremities, and trauma products, spine ... and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw ...

In a report released today, Caitlin Cronin from Canaccord Genuity maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report), ...

The firm spun out its dental and spine businesses in 2022. A Deep Dive into Zimmer Biomet Holdings's Financials Market Capitalization Analysis: Positioned below industry benchmarks, the company's ...

Zimmer Biomet Holdings ... Valued at $21.8 billion by market cap, the company offers orthopedic, dental, and spinal reconstructive implants, as well as bone cement and related surgical products.